Exchange: NASDAQ·Updated 07:30 PM EDT
NVCT logo

NVCT Nuvectis Pharma Inc

$23.73
$1.46
(5.80%)
Today
Closed $23.73
$0.00
(0.00%)
After Hours
Reported EarningsAug 4
Mkt Cap$822.3M
Vol137,204.00

About NVCT

Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900. The company was founded by Ronald E. Bentsur, Enrique Poradosu, and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
65

Bullish Sentiment

How do you feel about NVCT?

Advertisement|Remove ads.